Overview
Catherine Mark practices practicing medicine in Toronto, Canada.
Her clinical expertise encompasses Infantile Neutropenia, Wilms Tumor, Leukemia, and Severe Acute Respiratory Syndrome (SARS).
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Catherine Mark
Is Catherine Mark a top-rated expert for Infantile Neutropenia?
MediFind is an objective health platform that identifies experts based on real-world data. Catherine Mark is classified as an Experienced expert for Infantile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Catherine Mark participate in research or clinical trials?
Yes. Catherine Mark has published 11 articles and abstracts on conditions like Infantile Neutropenia. You can view a list of Catherine Mark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Infantile NeutropeniaMs. Mark isExperienced. Learn about Infantile Neutropenia.
- LeukemiaMs. Mark isExperienced. Learn about Leukemia.
- Severe Acute Respiratory Syndrome (SARS)
- Wilms TumorMs. Mark isExperienced. Learn about Wilms Tumor.